Chronic intracardiac thrombus, a long-term complication of COVID-19: Case reports

Umit Arslan1, Ferhat Borulu1, İbrahim Sarac2

  • 1Department of Cardiovascular Surgery, Ataturk University, Erzurum, Turkey.

Insights

Coronavirus disease 2019 (COVID-19) can cause long-term heart issues, including dangerous intracardiac thrombus, even after recovery. This study highlights two cases of chronic intracardiac thrombus in patients post-COVID-19 recovery.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pathophysiology

Background:

  • Coronavirus disease 2019 (COVID-19) is associated with significant inflammation and thrombogenic effects.
  • These effects can persist post-recovery, leading to serious cardiovascular complications.
  • Intracardiac thrombus formation is a critical, life-threatening complication that can result in sudden cardiac death.

Observation:

  • This study presents two cases of patients who had recovered from COVID-19.
  • Both patients presented with the development of chronic intracardiac thrombus.
  • The thrombus was identified after the acute phase of COVID-19 infection had resolved.

Findings:

  • The findings indicate a potential link between prior COVID-19 infection and the subsequent development of chronic intracardiac thrombus.
  • These cases underscore the prolonged cardiovascular risks associated with COVID-19.
  • The pathophysiology may involve persistent inflammatory and pro-thrombotic states induced by the virus.

Implications:

  • These observations suggest the need for vigilant cardiovascular monitoring in patients following COVID-19 recovery.
  • Early detection and management of intracardiac thrombus are crucial to prevent adverse outcomes such as sudden death.
  • Further research is warranted to elucidate the mechanisms linking COVID-19 to intracardiac thrombus and to establish optimal long-term management strategies.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
39
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
58
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
59
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
95
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
96
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54